Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.
Hervier
Baptiste
B
Masseau
Agathe
A
Mussini
Jean-Marie
JM
Audrain
Marie
M
Hamidou
Mohamed A
MA
D000328:Adult; D002097:C-Reactive Protein / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D046351:Protoporphyria, Erythropoietic / Q000188:drug therapy*; D011928:Raynaud Disease / Q000150:complications
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002097:C-Reactive Protein; D009173:Mycophenolic Acid; D008727:Methotrexate